These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2112727)

  • 21. Effect of melatonin on hypoglycemia and metoclopramide-stimulated arginine vasopressin secretion in normal men.
    Coiro V; Volpi R; Caffarri G; Capretti L; Marchesi C; Giacalone G; Chiodera P
    Neuropeptides; 1997 Aug; 31(4):323-6. PubMed ID: 9308018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in humans.
    Chiodera P; Gnudi A; Bianconi L; Capretti L; Fagnoni F; Volpi R; Coiro V
    Metabolism; 1989 Aug; 38(8):709-11. PubMed ID: 2569658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man.
    Coiro V; Volpi R; Maffei ML; Volta E; Melani A; Chiodera P
    Regul Pept; 2010 Jun; 162(1-3):1-4. PubMed ID: 20346989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man.
    Seckl JR; Johnson M; Shakespear C; Lightman SL
    Clin Endocrinol (Oxf); 1988 May; 28(5):509-14. PubMed ID: 3214943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
    Xiao E; Xia-Zhang L; Thornell D; Shalts E; Ferin M
    Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
    Coiro V; Chiodera P
    Neuroendocrinology; 1991 Mar; 53(3):209-13. PubMed ID: 2041583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men.
    Coiro V; Butturini U; Gnudi A; Delsignore R; Volpi R; Chiodera P
    Metabolism; 1986 Jul; 35(7):577-9. PubMed ID: 3523115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal arginine-vasopressin responses to metoclopramide and insulin-induced hypoglycemia in type I diabetes mellitus.
    Coiro V; Capretti L; Speroni G; Volpi R; Caiazza A; Rossi G; Bianconi L; Chiodera P
    Horm Res; 1990; 33(6):227-32. PubMed ID: 2289781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL; Irvine CH
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men.
    Coiro V; Casti A; Rubino P; Manfredi G; Maffei ML; Volta E; Cataldo S; Melani A; Saccani Jotti G; Chiodera P
    J Neural Transm (Vienna); 2008 Jun; 115(6):803-7. PubMed ID: 18259681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemia-induced inhibition of luteinizing hormone secretion in the rhesus monkey is not mediated by endogenous opioid peptides.
    Heisler LE; Pallotta CM; Reid RL; Van Vugt DA
    J Clin Endocrinol Metab; 1993 May; 76(5):1280-5. PubMed ID: 8388404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier.
    Chiodera P; Volpi R; Capretti L; Speroni G; Marcato A; Rossi G; Coiro V
    Neuroendocrinology; 1992 Jun; 55(6):655-9. PubMed ID: 1321355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.
    Wakabayashi I; Demura R; Miki N; Ohmura E; Miyoshi H; Shizume K
    J Clin Endocrinol Metab; 1980 Mar; 50(3):597-9. PubMed ID: 6987258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of vasopressin and opioids during rapid hemorrhage in conscious rabbits.
    Schadt JC; Hasser EM
    Am J Physiol; 1991 Feb; 260(2 Pt 2):R373-81. PubMed ID: 1847600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
    el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by dexamethasone of arginine vasopressin and ACTH responses to insulin-induced hypoglycemia and cigarette smoking in normal men.
    Chiodera P; Coiro V
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):487-92. PubMed ID: 2175139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for endogenous opioid control of vasopressin release in man.
    Lightman SL; Forsling ML
    J Clin Endocrinol Metab; 1980 Mar; 50(3):569-71. PubMed ID: 7358835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglycemia in normal weight bulimic women.
    Chiodera P; Volpi R; Marchesi C; Caffarra P; De Ferri A; Capretti L; Speroni G; d'Amato L; Coiro V
    Neuroendocrinology; 1993 May; 57(5):907-11. PubMed ID: 8413828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory control of nitric oxide on the arginine-vasopressin and oxytocin response to hypoglycaemia in normal men.
    Chiodera P; Volpi R; Coiro V
    Neuroreport; 1994 Sep; 5(14):1822-4. PubMed ID: 7530064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.